PNC Financial Services Group’s Organogenesis Holdings ORGO Stock Holding History
Bought
Maintained
Sold
Other funds holding ORGO
SCM
FLAM
VCM
PNC Financial Services Group's ORGO Position: Q1 2026 in Review
PNC Financial Services Group sold out of Organogenesis Holdings (ORGO) in Q1 2026, closing a stake of 5 shares — an estimated $26 sold.
PNC Financial Services Group first reported a position in ORGO in Q2 2021 and held it in 12 quarters. The position peaked at $42K in Q4 2021. 121 funds tracked by Wall St. Rank hold ORGO as of Q1 2026.
- PNC Financial Services Group reported no remaining Organogenesis Holdings position as of Q1 2026 after selling out during the quarter.
- PNC Financial Services Group sold 5 Organogenesis Holdings shares in Q1 2026, an estimated $26.
- PNC Financial Services Group first reported a position in Organogenesis Holdings in Q2 2021 and held it in 12 quarters.
- PNC Financial Services Group's Organogenesis Holdings position peaked at $42K in Q4 2021.
- 121 funds tracked by Wall St. Rank held Organogenesis Holdings as of Q1 2026.
Based on PNC Financial Services Group's 13F filing for Q1 2026, filed 8 May 2026.